Chelsea & Westminster Hospital launches diabetes care app
pharmafile | February 2, 2021 | News story | Manufacturing and Production |
Chelsea and Westminster Hospital NHS Foundation Trust have today announced the use of a new app designed to revolutionise diabetes care from home.
The DBm-Health app, which was co-designed by Sensyne Health, has been introduced in response to the COVID-19 pandemic, which has severely impacted the hospital’s ability to manage patient care in-person.
Using the app, patients can work with their clinician to develop a personalised care plan comprising lifestyle advice, treatment, and clear targets for blood glucose control.
Patients can input their own glucose readings or use a Bluetooth glucose meter to send their readings to their clinician, who can:
- Identify patients whose glucose readings are out of range, allowing targeted support
- Filter patient lists to help prioritise interventions
- Message patients via the app or by text message
The DBm-Health app is one of many new changes planned by the CW Innovation programme, a partnership between the Trust and CW+, the Trust’s charity. Long-term conditions such as diabetes fit the new model of home care, which, the Trust believes, is not only more convenient but currently safer too.
Dr Daniel Morganstein, Endocrinologist and Diabetes Specialist at Chelsea and Westminster Hospital NHS Foundation Trust, said: “DBm-Health has the potential to radically improve how we manage our patients, especially those benefiting from additional support in self-management. It uses only a standard glucose meter available to almost all people living with diabetes.
“We’re excited by the possibilities of this technology, which comes at a time when we’re trying to care for patients without them having to come in the hospital.
“We hope the new DBm-Health system will enable us to care for more patients by significantly reducing the time taken to contact patients by phone or email to review their data, and allow the team to focus on those needing support.”